» Articles » PMID: 31929812

Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson's Disease Through the Inflammation Pathway

Overview
Date 2020 Jan 14
PMID 31929812
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic neurons in the substantia nigra (SN)-striatum circuit, which is associated with glial activation and consequent chronic neuroinflammation. Optimized Yinxieling Formula (OYF) is a Chinese medicine that exerts therapeutical effect and antiinflammation property on psoriasis. Our previous study has proven that pretreatment with OYF could regulate glia-mediated inflammation in an acute mouse model of PD induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Given that PD is a chronic degeneration disorder, this study applied another PD animal model induced by striatal injection of 6-hydroxydopamine (6-OHDA) to mimic the progressive damage of the SN-striatum dopamine system in rats. The OYF was administrated in the manner of pretreatment plus treatment. The effects of the OYF on motor behaviors were assessed with the apomorphine-induced rotation test and adjusting steps test. To confirm the effect of OYF on dopaminergic neurons and glia activation in this model, we analyzed the expression of tyrosine hydroxylase (TH) and glia markers, ionized calcium-binding adapter molecule 1 (Iba-1), and glial fibrillary acidic protein (GFAP) in the SN region of the rat PD model. Inflammation-associated factors, including tumor necrosis factor- (TNF-), interleukin-1 (IL-1), IL-6, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2), were further evaluated in this model and in interferon-- (INF--) induced murine macrophages RAW264.7 cells. The results from the study showed that OYF reversed the motor behavioral dysfunction in 6-OHDA-induced PD rats, upregulated the TH expression, decreased the immunoreactivity of Iba-1 and GFAP, and downregulated the mRNA levels of TNF- and COX-2. The OYF also trended to decrease the mRNA levels of IL-1 and iNOS . The results from the study showed that OYF significantly decreased the mRNA levels of TNF-, IL-1, IL-6, iNOS, and COX-2. Therefore, this study suggests that OYF exerts antiinflammatory effects, which might be related to the protection of dopaminergic neurons in 6-OHDA-induced chronic neurotoxicity.

Citing Articles

Neuroprotective and Anti-inflammatory Effects of Rubiscolin-6 Analogs with Proline Surrogates in Position 2.

Perlikowska R, Silva J, Alves C, Susano P, Zaklos-Szyda M, Skibska A Neurochem Res. 2023; 49(4):895-918.

PMID: 38117448 PMC: 10901950. DOI: 10.1007/s11064-023-04070-z.


Diverse Galactooligosaccharides Differentially Reduce LPS-Induced Inflammation in Macrophages.

Sun C, Hao B, Pang D, Li Q, Li E, Yang Q Foods. 2022; 11(24).

PMID: 36553716 PMC: 9777761. DOI: 10.3390/foods11243973.


Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease via inhibiting oxidative stress.

Nourmohammadi S, Yousefi S, Manouchehrabadi M, Farhadi M, Azizi Z, Torkaman-Boutorabi A BMC Complement Med Ther. 2022; 22(1):40.

PMID: 35144603 PMC: 8832724. DOI: 10.1186/s12906-022-03524-1.


Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson's Disease via Activating the JAK2/STAT3 Pathway.

Xu Z, Yang D, Huang X, Huang H Front Neurosci. 2021; 15:631501.

PMID: 33833662 PMC: 8021720. DOI: 10.3389/fnins.2021.631501.


Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.

Guzelad O, Ozkan A, Parlak H, Sinen O, Afsar E, Ogut E Metab Brain Dis. 2021; 36(5):1003-1014.

PMID: 33666819 DOI: 10.1007/s11011-021-00704-9.

References
1.
Shinmura K, Xuan Y, Tang X, Kodani E, Han H, Zhu Y . Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res. 2002; 90(5):602-8. DOI: 10.1161/01.res.0000012202.52809.40. View

2.
Burke S, Updegraff B, Bellich R, Goff M, Lu D, Minkin Jr S . Regulation of iNOS gene transcription by IL-1β and IFN-γ requires a coactivator exchange mechanism. Mol Endocrinol. 2013; 27(10):1724-42. PMC: 5427878. DOI: 10.1210/me.2013-1159. View

3.
Lu C, Xiang Y, Xie X, Xuan M, He Z . A randomized controlled single-blind clinical trial on 84 outpatients with psoriasis vulgaris by auricular therapy combined with optimized Yinxieling Formula. Chin J Integr Med. 2012; 18(3):186-91. DOI: 10.1007/s11655-012-1020-3. View

4.
Han L, Sun J, Lu C, Zhao R, Lu Y, Lin H . Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression. Int Immunopharmacol. 2017; 44:226-233. DOI: 10.1016/j.intimp.2017.01.023. View

5.
Long-Smith C, Sullivan A, Nolan Y . The influence of microglia on the pathogenesis of Parkinson's disease. Prog Neurobiol. 2009; 89(3):277-87. DOI: 10.1016/j.pneurobio.2009.08.001. View